Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultcardiovascular eventsCardiovascular death

diabetes type 2  

ALECARDIO    NCTaleglitazarplacebo -
ALEPREVENT     aleglitazarplaceboLow risk of bias -
ALECARDIO, 2014      NCTaleglitazarplaceboLow risk of bias negative-4%15%